Piotr Czaykowski

Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206

Brian I. Rini, Susan Halabi, Jonathan E. Rosenberg et al. · Journal of Clinical Oncology · 2008 · 908 citations · Full text

Medicine, Oncology, Pharmacology +10

Randomized Phase II Trial of Custirsen (OGX-011) in Combination with Docetaxel or Mitoxantrone as Second-line Therapy in Patients with Metastatic Castrate-Resistant Prostate Cancer Progressing after First-line Docetaxel: CUOG Trial P-06c

Fred Saad, Sebastién J. Hotte, Scott North et al. · Clinical Cancer Research · 2011 · 128 citations · Full text

Medicine, Oncology, Pharmacology +15

Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study

Patrick Cheung, Samir Patel, Scott North et al. · European Urology · 2021 · 125 citations

Medicine, Oncology, Radiation Oncology +16

A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer

K.N. Chi, Susan Ellard, Sebastién J. Hotte et al. · Annals of Oncology · 2007 · 118 citations · Full text

Medicine, Oncology, Urology +13

HIGH RISK OF VASCULAR EVENTS IN PATIENTS WITH UROTHELIAL TRANSITIONAL CELL CARCINOMA TREATED WITH CISPLATIN BASED CHEMOTHERAPY

Piotr Czaykowski, Malcolm J. Moore, Ian F. Tannock · The Journal of Urology · 1998 · 116 citations

Medicine, Oncology, Pharmacology +13